Search

everythinglearnresearchcommunity

for

Search:↓

Abnormal keratin expression in mice causes severe oral issues, affecting feeding.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Chronic cutaneous lupus erythematosus causes scarring, hair loss, and skin discoloration, especially on sun-exposed areas.

Feline cutaneous lymphocytosis is likely reactive, while canine cutaneous lymphocytosis needs more study to understand its nature.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

The study concluded that careful examination is key to differentiate between lipidized fibrous histiocytoma and juvenile xanthogranuloma.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

3D spheroid culture makes stem cells better at reducing inflammation.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Folliculotropic Mycosis Fungoides requires stage-based treatment, with early stages using skin therapies and advanced stages needing aggressive treatments.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Myasthenia gravis can affect both motor and non-motor systems due to immune system issues.

Thymoma with alopecia areata may be linked to abnormal immune cells.

A woman's hair loss improved after removing a tumor in her thymus gland, suggesting hair loss can be linked to such tumors even without a specific muscle weakness condition.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.

The guide explains how to study human and mouse sebaceous glands using various staining and imaging techniques, and emphasizes the need for standardized assessment methods.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

IL-17-producing γδ T cells help improve bone healing.

Telocytes in the scalp may help with skin regeneration and maintenance.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Trichofolliculoma is a unique benign tumor mainly affecting middle-aged adults' faces, often misdiagnosed without histopathology.